SEC EDGAR filings, ownership reports, and insider transactions for ARCH Venture Fund VII, L.P..
Recent SEC filings for ARCH Venture Fund VII, L.P. including SCHEDULE 13G/A, 4, SC 13G/A and more.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 14 Nov 2025 | |||
| 4 | Open 4 document | View SEC filing for 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 29 Oct 2025 | 27 Oct 2025 | 001-41802 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | ARCH VENTURE FUND VII, L.P. - 908 DEVICES INC. -- SCH 13G/A(#4) | 14 Nov 2024 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | ARCH VENTURE FUND VII, L.P. - 908 DEVICES INC. -- SCH 13G/A(#3) | 09 Feb 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 12 Dec 2023 | 08 Dec 2023 | 001-41802 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Sep 2023 | 19 Sep 2023 | 001-41802 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 14 Sep 2023 | 14 Sep 2023 | 001-41802 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | ARCH VENTURE FUND VII, L.P. - 908 DEVICES INC. -- SCH 13G/A(#2) | 13 Feb 2023 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | ARCH VENTURE FUND VII, L.P. - UNITY BIOTECHNOLOGY -- SCH 13G/A (#3) | 11 Feb 2022 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | ARCH VENTURE FUND VII, L.P. - 908 DEVICES INC. -- SCH 13G/A(#1) | 08 Feb 2022 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | ARCH VENTURE FUND VII, L.P. - 908 DEVICES INC. -- SCH 13G | 04 Feb 2021 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | ARCH VENTURE FUND VII, L.P. - UNITY BIOTECHNOLOGY -- SCH 13G/A (#2) | 02 Feb 2021 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | ARCH VENTURE FUND VII, L.P. - TWIST BIOSCIENCE -- SCH 13G/A (#2E) | 02 Feb 2021 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | ARCH VENTURE FUND VII, L.P. - SYROS PHARMACEUTICALS -- SCH 13G/A (#4E) | 02 Feb 2021 | ||
| 4 | Open 4 document | View SEC filing for 4 | OWNERSHIP DOCUMENT | 22 Dec 2020 | 22 Dec 2020 | 001-39815 |
| 3 | Open 3 document | View SEC filing for 3 | OWNERSHIP DOCUMENT | 17 Dec 2020 | 17 Dec 2020 | 001-39815 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | ARCH VENTURE FUND VII, L.P. - TWIST BIOSCIENCE CORPORATION -- SCHEDULE 13G/A(#1) | 14 Feb 2020 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | ARCH VENTURE FUND VII, L.P. - UNITY BIOTECHNOLOGY, INC. -- SCHEDULE 13G/A(#1) | 13 Feb 2020 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | ARCH VENTURE FUND VII, L.P. - SYROS PHARMACEUTICALS, INC. -- SCHEDULE 13G/A(#3) | 13 Feb 2020 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | ARCH VENTURE FUND VII, L.P. - SCHEDULE 13D/A - AMENDMENT NO. 5E | 25 Jul 2019 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 17 Jul 2019 | 15 Jul 2019 | 001-37813 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | ARCH VENTURE FUND VII, L.P. - SCHEDULE 13D/A - AMENDMENT NO. 4 | 22 Mar 2019 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Mar 2019 | 12 Mar 2019 | 001-37813 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 11 Mar 2019 | 07 Mar 2019 | 001-37813 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | ARCH VENTURE FUND VII, L.P. - UNITY BIOTECHNOLOGY, INC. -- SCHEDULE 13G | 14 Feb 2019 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | ARCH VENTURE FUND VII, L.P. - TWIST BIOSCIENCE CORPORATION -- SCHEDULE 13G | 14 Feb 2019 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | ARCH VENTURE FUND VII, L.P. - SYROS PHARMACEUTICALS, INC. -- SCHEDULE 13G/A(#2) | 14 Feb 2019 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Nov 2018 | 02 Nov 2018 | 001-38720 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 30 Oct 2018 | 30 Oct 2018 | 001-38720 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 | 07 May 2018 | 07 May 2018 | 001-38470 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 | 03 May 2018 | 02 May 2018 | 001-38470 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 12 Apr 2018 | 03 Apr 2018 | 001-36199 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SCHEDULE 13D/A - AMENDMENT NO. 3 | 12 Apr 2018 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Apr 2018 | 03 Apr 2018 | 001-36199 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | ARCH VII - JUNO THERAPEUTICS, INC. 13GA(#4E) | 09 Mar 2018 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | ARCH VII - SYROS PHARMACEUTICALS 13GA(#1) | 02 Feb 2018 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | ARCH VII - JUNO THERAPEUTICS, INC. 13GA(#3) | 02 Feb 2018 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SCHEDULE 13D/A - AMENDMENT NO. 2 | 05 Jan 2018 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SCHEDULE 13D/A - AMENDMENT NO. 1 | 15 Feb 2017 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | JUNO THERAPEUTICS, INC. - SCHEDULE 13G (AMEND. #2) | 13 Feb 2017 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SYROS PHARMACEUTICALS, INC. -- SCHEDULE 13G/A (AMEND. #1) | 13 Feb 2017 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 07 Jul 2016 | 06 Jul 2016 | 001-37813 |
| 3 | Open 3 document | View SEC filing for 3 | 3 | 29 Jun 2016 | 29 Jun 2016 | 001-37813 |
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | 06 Jun 2016 | |||
| 4 | Open 4 document | View SEC filing for 4 | OWNERSHIP DOCUMENT | 25 May 2016 | 23 May 2016 | 001-37772 |
| 3/A | Open 3/A document | View SEC filing for 3/A | OWNERSHIP DOCUMENT | 23 May 2016 | 17 May 2016 | 001-37772 |
| 3 | Open 3 document | View SEC filing for 3 | OWNERSHIP DOCUMENT | 17 May 2016 | 17 May 2016 | 001-37772 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 17 Mar 2016 | 15 Mar 2016 | 001-36781 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | AGIOS PHARMACEUTICALS, INC.-AMEND. #2 | 11 Feb 2016 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | JUNO THERAPEUTICS, INC. - AMEND. #1 | 11 Feb 2016 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SAGE THERAPEUTICS, INC.-AMEND. #1 | 11 Feb 2016 | ||
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | SC 13D | 25 Jun 2015 | ||
| 4/A | Open 4/A document | View SEC filing for 4/A | OWNERSHIP DOCUMENT | 25 Jun 2015 | 15 Jun 2015 | 001-36199 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Jun 2015 | 18 Jun 2015 | 001-36544 |
| 4 | Open 4 document | View SEC filing for 4 | OWNERSHIP DOCUMENT | 17 Jun 2015 | 15 Jun 2015 | 001-36199 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 | 17 Jun 2015 | 15 Jun 2015 | 001-36199 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | RECEPTOS, INC. | 11 Jun 2015 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 23 Feb 2015 | 19 Feb 2015 | 001-36014 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | BLUEBIRD BIO, INC. | 11 Feb 2015 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | BIND THERAPEUTICS | 11 Feb 2015 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | AGIOS PHARMACEUTICALS, INC. | 11 Feb 2015 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | JUNO THERAPEUTICS, INC. | 11 Feb 2015 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SAGE THERAPEUTICS, INC. | 11 Feb 2015 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 16 Jan 2015 | 14 Jan 2015 | 001-36544 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 23 Dec 2014 | 23 Dec 2014 | 001-36781 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 18 Dec 2014 | 18 Dec 2014 | 001-36781 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 19 Sep 2014 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 18 Aug 2014 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 23 Jul 2014 | 23 Jul 2014 | 001-36544 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 17 Jul 2014 | 17 Jul 2014 | 001-36544 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 25 Jun 2014 | 23 Jun 2014 | 001-36014 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 15 May 2014 | 13 May 2014 | 001-35900 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | BLUEBIRD BIO, INC. | 06 Feb 2014 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | BIND THERAPEUTICS | 06 Feb 2014 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | AGIOS PHARMACEUTICALS | 06 Feb 2014 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 31 Jul 2013 | 29 Jul 2013 | 001-36014 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 23 Jul 2013 | 23 Jul 2013 | 001-36014 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 26 Jun 2013 | 24 Jun 2013 | 001-35966 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 18 Jun 2013 | 18 Jun 2013 | 001-35966 |
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | RECEPTOS, INC. | 17 May 2013 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 14 May 2013 | 14 May 2013 | 001-35900 |
| 3 | Open 3 document | View SEC filing for 3 | 3 | 08 May 2013 | 08 May 2013 | 001-35900 |
ARCH Venture Fund VII, L.P. files with the SEC under CIK 0001402439. This page aggregates EDGAR filings and related ownership activity.